| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917729 | Radiotherapy and Oncology | 2016 | 5 Pages |
Abstract
We have demonstrated IN of prePET and iPET to be a feasible and potentially useful novel imaging biomarker to predict for patients with NPC who have a high risk of regional or distant metastatic failure. Future work is required to validate our findings in a well-powered, prospective study with a standardised treatment protocol, and their potential use to guide individualised therapy for NPC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Peter Lin, Myo Min, Mark Lee, Lois Holloway, Dion Forstner, Victoria Bray, Wei Xuan, Andrew Chicco, Allan Fowler,